Chalfont St. Giles and Stevenage, UK - 29 October 2013. GE Healthcare Life Sciences, a global provider of tools, technologies and services for life science research and for the manufacturing of biopharmaceuticals, today announced the opening of a Technology Laboratory at Stevenage Bioscience Catalyst, the UK's first open innovation bioscience campus.
Princeton, NJ, September 30, 2013 -- GE Healthcare Life Sciences today announced that its Radiopharmacy Services division has earned The Joint Commission's Gold Seal of Approval™ for accreditation by demonstrating compliance with The Joint Commission's national standards for health care quality and safety.[i] GE Healthcare's national network of 31 Radiopharmacies are accredited as part of The Joint Commission's Home Care Accreditation program.
business unit
tags
Eurofins Scientific (EUFI.PA), the world leader in food, environment and pharmaceutical products testing, has signed an agreement with GE Healthcare for the exclusive right to offer GE Healthcare's Cytiva™ Cardiomyocytes for drug discovery and early development cardio toxicity screening services.